IFNG and inflammatory bowel disease: Collectively, our data revealed that PO as an protect animal against experimental IBD via inhibiting the infiltration of pro-inflammatory Th1 and Th17 cells, suppressing MPO activity and decreasing inflammatory cytokines, i.e., IFN-γ, IL-12p70, IL-17A, and IL-10.